Vinpocetine Velpharm  

Vinpocetine Velpharm



Active ingredient (INN)
Composition (active ingredients)
vinpocetine - 5,0 mg
Фармакотерапевтическая группа
psychostimulating and nootropic agent
Pharmacotherapeutic group
concentrate for solution for infusion 5 mg / ml 2 ml № 10
Сonditions of supply
on prescription


Neurology: symptomatic treatment of the consequences of ischemic stroke, vascular arterio-basilar insufficiency, vascular dementia, atherosclerosis, cerebral vessels, post-traumatic, hypertensive encephalopathy;
Ophthalmology: chronic vascular diseases of the retina and choroid;
Otology: perceptual hearing loss, Meniere's disease, tinnitus.
Dosage regimen

Dosage regimen

The drug is intended only for intravenous drip infusion, administered slowly (infusion rate should not exceed 80 drops/min). 

To prepare the infusion, you can use a solution of sodium chloride 0,9% or solutions containing dextrose. 

The initial daily dose is 20 mg in 500 ml of 0,9% sodium chloride solution or solutions containing dextrose. With good tolerance for 2-3 days, the dose is increased to a maximum of 1 mg/kg/day. 

The average duration of treatment is 10-14 days.

The average daily dose with a body weight of 70 kg is 50 mg.

After the end of the course of parenteral administration, they switch to the oral administration of the drug. Before discontinuing the drug, the dose should be gradually reduced.

For liver or kidney disease, dose adjustment is not required.
The dosage form concentrate for the preparation of a solution for infusion requires mandatory dilution!
The infusion solution should be used within 3 hours of preparation.


There are contraindications, consult with a specialist before use

Other products in this category